Matthias K. Bernhard

Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age – a multicenter retrospective study

Afshin Saffari, Ines Brösse, Adelheid Wiemer‐Kruel et al. · Orphanet Journal of Rare Diseases · 2019 · 124 citations · Full text

47 patients with FLNA associated periventricular nodular heterotopia

Max Lange, Burkhard S. Kasper, Axel Bohring et al. · Orphanet Journal of Rare Diseases · 2015 · 105 citations · Full text

Expression of purinergic receptors (ionotropic P2X1–7 and metabotropic P2Y1–11) during myeloid differentiation of HL60 cells

Kathrin Adrian, Matthias K. Bernhard, Hans‐Georg Breitinger et al. · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · 2000 · 79 citations

Molecular Pharmacology, Myeloid Differentiation, Signal Transduction +12

Use of complementary and alternative medicine (CAM) by parents in their children and adolescents with epilepsy – Prevelance, predictors and parents' assessment

Nicole Hartmann, Martina Patrizia Neininger, Matthias K. Bernhard et al. · European Journal of Paediatric Neurology · 2015 · 56 citations

Family Medicine, Adolescent Medicine, Alternative Medicine +8

Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors

Peter Werner, Henryk Barthel, Ulf Nestler et al. · Child s Nervous System · 2014 · 52 citations

Positron Emission Tomography, Neuro-oncology, Pediatric Brain Tumors +14